About Spectradyne
Spectradyne is a company based in Torrance (United States) founded in 2013. Spectradyne offers products and services including ARC, nCS2, nCS1, and Cartridges. Spectradyne operates in a competitive market with competitors including Halo Labs, Qnami, Spheryx, ATLANT 3D and Molecular Vista, among others.
- Headquarter Torrance, United States
- SectorsHealthcareTechnology Industrial Goods & Manufacturing
- Email••••••••
- Website nanoparticleanalyzer.com
- Social LinkedIn X Facebook YouTube
- Legal Name Spectradyne Llc
- Latest Funding Round$1.91M (USD), Grant
May 2020
- Investors
Products & Services of Spectradyne
Spectradyne offers a comprehensive portfolio of products and services, including ARC, nCS2, nCS1, and Cartridges.
Instrument for sizing and fluorescent analysis of nanoparticles.
Device for measuring particle concentration and size distributions.
System for accurate nano-scale particle analysis in samples.
Consumables for microfluidic sensing in nanoparticle applications.
Apps and channels of Spectradyne
its YouTube channel Spectradyne Particle Analysis has 56 subscribers and 30 videos.
Videos from Spectradyne
The most watched videos on Spectradyne's YouTube channel, Spectradyne Particle Analysis (56 subscribers). Click a video to play it here.
More on Spectradyne Particle Analysis.
Funding Insights of Spectradyne
- Total Rounds 4
- Last Round Grant — $1.91M
- First Round $179,999
(Jul 2014)
- Investors Count 1
All 4 funding rounds of Spectradyne with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Spectradyne
Spectradyne has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Spectradyne
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Spectradyne
3 dated milestones of Spectradyne across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Spectradyne is founded.
- Funding First funding round of $180K.
- Funding Latest funding round, Grant, of $1.9M.
Competitors of Spectradyne
Spectradyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Qnami, Spheryx, ATLANT 3D and Molecular Vista, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| halolabs.com | 2010 | Burlingame, United States | $23.7M | – | Developer of subvisible particle analyzer for life science and materials applications | |
| qnami.ch | 2016 | Muttenz, Switzerland | $7.19M | – | Quantum-based scanning probe microscopes for field measurements are developed. | |
| spheryx.solutions | 2014 | New York, United States | $1.78M | – | Analytical instruments company developing instruments for non-destructive, quantitative measurements of suspended particles | |
| atlant3d.com | 2018 | Kongens Lyngby, Denmark | $30M | 35 | 3D printers are manufactured using nanotechnology for microdevice prototyping. | |
| molecularvista.com | 2011 | San Jose, United States | $660,000 | 11 | Manufacturer of photo-induced force microscopic (PiFM) systems | |
| infinitesima.com | 2001 | Abingdon, United Kingdom | $217,650 | 29 | Atomic precision 3D metrology technology is developed for semiconductor manufacturing. | |
| vanguard-automation.com | 2017 | Karlsruhe, Germany | – | – | 3D printing technology for electronics nanofabrication is provided. | |
| insplorion.com | 2010 | Gothenburg, Sweden | $410,000 | 8 | Instruments for nanomaterial characterization using plasmonic resonance are developed. | |
| interfacefluidics.com | 2015 | Edmonton, Canada | $9.88M | – | Nanotech-enabled platform for fluid interaction simulations in reservoirs is provided. |
Detailed competitors of Spectradyne
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Spectradyne
The website of Spectradyne (nanoparticleanalyzer.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 58.9% vs previous month
Similar companies to Spectradyne
10 companies that operate in the same segment as Spectradyne (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spectradyne
Spectradyne was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Spectradyne is headquartered in Torrance, United States. It is registered at Torrance, California, United States.
Spectradyne was founded in 2013 and is based in Torrance, United States. Operations focus on the nanotechnology sector, where nanoparticle analyzers are produced for applications in research, biomedical fields, and materials science. Resistive pulse sensing technology is employed in these devices to enable accurate counting and sizing of nanoparticles, differing from methods like dynamic light scattering. Software and consumables are also provided to support the primary instrument.
Spectradyne's top competitors include Halo Labs, ATLANT 3D and Infinitesima.
Spectradyne offers ARC, nCS2, nCS1, and Cartridges.
Spectradyne has 1 investor. Key investors include HHS.
Spectradyne operates through Spectradyne Llc.